The 5th Circuit Court of Appeals is hearing a case that could potentially restrict access to the abortion pill mifepristone. The anti-abortion plaintiffs argue that the FDA acted outside of its authority when it approved and expanded access to the drug. Judges, all Republican appointees, appeared to be leaning toward restricting access, which could have a major impact on women's access to safe and legal abortions in the United States. A ruling is expected in the coming weeks.
